Compounds > cidofovir anhydrous
Page last updated: 2024-08-24

cidofovir anhydrous and Neutropenia

cidofovir anhydrous has been researched along with Neutropenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hishizawa, M; Kondo, T; Matsumoto, K; Shimizu, T; Takaori-Kondo, A; Yamashita, K1
Dietz, A; Dikkers, FG; Djukic, V; Eckel, HE; Friedrich, G; Golusinski, W; Hantzakos, A; Lawson, G; Remacle, M; Rihkanen, H; Tjon Pian Gi, RE1
Aaltonen, LM; Andersen, J; Brunings, JW; Chirila, M; de Gier, HH; Dietz, A; Dikkers, FG; Ferran Vilà, F; Friedrich, G; Golusinski, W; Graupp, M; Hantzakos, A; Horcasitas, R; Ilmarinen, T; Jackowska, J; Koelmel, JC; Lawson, G; Lindner, F; Remacle, M; Sittel, C; Tjon Pian Gi, RE; van den Heuvel, ER; Weichbold, V; Wierzbicka, M1

Other Studies

3 other study(ies) available for cidofovir anhydrous and Neutropenia

ArticleYear
Neutropenia and renal dysfunction due to intravesical cidofovir for virus-associated hemorrhagic cystitis after kidney and allogenic hematopoietic stem cell transplantations.
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:6

    Topics: Administration, Intravesical; Allografts; Cidofovir; Cystitis; Hematopoietic Stem Cell Transplantation; Hematuria; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Neutropenia; Tissue Distribution; Transplantation, Homologous; Urinary Bladder

2019
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2012, Volume: 269, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Antiviral Agents; Cidofovir; Cytosine; Injections, Intralesional; Neoplasms; Neutropenia; Off-Label Use; Organophosphonates; Papilloma; Papillomavirus Infections; Recurrence; Renal Insufficiency; Respiratory Tract Infections

2012
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013, Volume: 270, Issue:5

    Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Female; Head and Neck Neoplasms; Humans; Injections, Intralesional; Male; Neutropenia; Off-Label Use; Organophosphonates; Papillomavirus Infections; Renal Insufficiency; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome

2013